Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. (2016)
Attributed to:
Molecular and Structural Basis of Cell Entry by Emerging and Zoonotic RNA Viruses
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/infdis/jiv565
PubMed Identifier: 26715676
Publication URI: http://europepmc.org/abstract/MED/26715676
Type: Journal Article/Review
Volume: 213
Parent Publication: The Journal of infectious diseases
Issue: 7
ISSN: 0022-1899